Effect of depression disorder on the efficacy and quality of life of first-line chemotherapy combined with immunotherapy in oncogene-driver negative NSCLC patients

Effect of depression disorder on the efficacy and quality of life of first-line chemotherapy combined with immunotherapy in oncogene-driver negative NSCLC patients

ObjectiveThe current research was to assess the relevance between depression disorder and first-line chemotherapy combined with immunotherapy, quality of life in patients with oncogene-driver negative non-small cell cancer (NSCLC).MethodsNSCLC patients (33 with depression disorder and 34 with no dep...

Full description

Bibliographic Details
Main Authors: Wen Li, Ziran Bi, Junxu Wu, Xu Duan, Lulian Pang, Yanyan Jing, Xiangxiang Yin, Huaidong Cheng
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Oncology
Subjects:
depression disorder
immunotherapy
chemotherapy
NCCLC
quality of life
first-line
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.772102/full

Similar Items

Similar Items